These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 33646611

  • 1. Implementing an integrated multi-technology platform for drug checking: Social, scientific, and technological considerations.
    Wallace B, Hills R, Rothwell J, Kumar D, Garber I, van Roode T, Larnder A, Pagan F, Aasen J, Weatherston J, Gozdzialski L, Ramsay M, Burek P, Azam MS, Pauly B, Storey MA, Hore D.
    Drug Test Anal; 2021 Apr; 13(4):734-746. PubMed ID: 33646611
    [Abstract] [Full Text] [Related]

  • 2. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
    Gozdzialski L, Wallace B, Hore D.
    Harm Reduct J; 2023 Mar 25; 20(1):39. PubMed ID: 36966319
    [Abstract] [Full Text] [Related]

  • 3. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW, Gill CG.
    J Mass Spectrom; 2019 Sep 25; 54(9):729-737. PubMed ID: 31432563
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A qualitative assessment of key considerations for drug checking service implementation.
    Grace Rose C, Pickard AS, Kulbokas V, Hoferka S, Friedman K, Epstein J, Lee TA.
    Harm Reduct J; 2023 Oct 17; 20(1):151. PubMed ID: 37848875
    [Abstract] [Full Text] [Related]

  • 7. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG.
    Drug Alcohol Rev; 2022 Feb 17; 41(2):410-418. PubMed ID: 34347332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L.
    Am J Drug Alcohol Abuse; 2020 Jul 03; 46(4):506-511. PubMed ID: 31983241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies.
    Bhuiyan I, Tobias S, Ti L.
    Am J Drug Alcohol Abuse; 2023 Nov 02; 49(6):685-690. PubMed ID: 37506334
    [Abstract] [Full Text] [Related]

  • 14. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
    Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC.
    Harm Reduct J; 2022 Feb 04; 19(1):9. PubMed ID: 35120531
    [Abstract] [Full Text] [Related]

  • 15. Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications.
    Sisco E, Nestadt DF, Bloom MB, Schneider KE, Elkasabany RA, Rouhani S, Sherman SG.
    Drug Test Anal; 2024 Sep 04; 16(9):942-947. PubMed ID: 38043944
    [Abstract] [Full Text] [Related]

  • 16. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E.
    Drug Alcohol Depend; 2018 Sep 01; 190():242-245. PubMed ID: 30064061
    [Abstract] [Full Text] [Related]

  • 17. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM, McDonald K, Maghsoudi N, Thompson H, Stefan C, Beriault DR, Delaney S, Wong E, Werb D.
    Harm Reduct J; 2021 Oct 13; 18(1):104. PubMed ID: 34645480
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B, van Roode T, Burek P, Hore D, Pauly B.
    Harm Reduct J; 2022 Dec 20; 19(1):143. PubMed ID: 36539747
    [Abstract] [Full Text] [Related]

  • 20. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C, Matsumoto A, Boulad M, Stopka TJ.
    Subst Use Misuse; 2023 Dec 20; 58(12):1528-1535. PubMed ID: 37424449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.